BSCL2 and progressive myoclonus epilepsy: This finding strengthens the evidence for the coexistence of PME and BSCL2 mutations, as previously suggested in the literature (Zhang et al., 2019; Opri et al., 2016; Ferranti et al., 2020; Serino et al., 2019).